PGZ 15 (Pioglitazone hydrochloride 15 mg (base))

Pill imprint PGZ 15 has been identified as Pioglitazone hydrochloride 15 mg (base).

Pioglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Pioglitazone 15 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Pioglitazone hydrochloride

Imprint:

PGZ 15

Strength:

15 mg (base)

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Thiazolidinediones

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Breckenridge Pharmaceutical, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.